Laborie Medical Technologies is a prominent global developer, manufacturer, and marketer of medical technology and consumables aimed at diagnosing and treating urinary and fecal incontinence, along with other pelvic floor disorders. The company's focus encompasses urology, urogynecology, and gastroenterology, where it specializes in diagnostic and therapeutic equipment. Laborie's offerings include advanced urodynamic testing devices that help identify the underlying causes of urinary incontinence, enabling effective treatment solutions for healthcare providers. Laborie is owned by Audax Group Private Equity, based in Boston, MA.
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%). Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Since its inception in 1993, Clinical Innovations has consistently expanded its worldwide presence, becoming the market leader in several product categories. This growth has fueled the ability to invest in new product ideas where innovation makes the difference. And with a management team with extensive experience in the medical device industry, Clinical Innovations possesses the working knowledge to develop those new product ideas into industry-changing specialty devices. Clinical Innovations is dedicated to quality and customer service. With ISO13485 certification and strong relationships with top worldwide medical distributors, Clinical Innovations has the systems and infrastructure in place to promptly respond to market trends and customer suggestions. Clinical Innovations is a Prizker Group Company.
Cogentix Medical is a medical device company that specializes in the design, development, manufacturing, and marketing of fiberoptic and video endoscopy products, primarily under the PrimeSight brand. Its product portfolio includes a variety of endoscopes such as cystoscopes and bronchoscopes, as well as specialized devices like the EndoSheath Protective Barrier, a single-use microbial barrier for flexible endoscopes. The company also offers the Urgent PC System, which provides percutaneous tibial nerve stimulation for treating overactive bladder, and Macroplastique, an injectable solution for adult female stress urinary incontinence. Additionally, Cogentix Medical distributes wound care products in the Netherlands and the United Kingdom. Established in 2015 through the merger of Uroplasty and Vision-Sciences, the company sells its products via a direct sales force and distributor networks, and is headquartered in Minnetonka, Minnesota.
ANDROMEDA medizin Systeme GmbH was founded in 1994. ANDROMEDA develops and markets modern and high-quality Urodynamic instruments. As a specialist and pioneer, the company is now one of the world's leading manufacturers of urodynamics.
Medi-Tate Ltd. is an Israeli medical device company focused on enhancing men's healthcare through innovative solutions. The company manufactures and sells iTIND, a temporarily implanted nitinol device designed to treat benign prostatic hyperplasia (BPH). This device offers long-lasting relief from BPH symptoms via a short, non-surgical procedure, marking a significant advancement in the management of this condition. iTIND is currently CE Marked, allowing it to be sold within the European Union. Founded in 2007 and based in Or Akiva, Israel, Medi-Tate aims to improve the quality of life for men by providing effective, office-based procedures for BPH treatment.
Medical Measurement Systems
Acquisition in 2015
Medical Measurement Systems engages in Gastrointestinal Diagnostics and Urodynamics. Medical Measurement Systems offers Uroflowmetry, a screening procedure to calculate the amount of urine; Urodynamics, which investigates the function of the lower urinary tract.
Unisensor specializes in the development and manufacture of micro, high resolution sensors to measure pressure and pH values for the Gastroenterology and Urology markets.
As medical technology company, we specialize in therapy, diagnostic equipment and supply of EMG -home biofeedback, electrical stimulation and combination systems for applications in incontinence - and pain therapy area for the diagnosis and rehabilitation medicine (gynecology, urology, Coloproctology, neurology, speech therapy) , the clinical psychological treatment, as well as urodynamic, anorectal measuring stations and makeshift medical.
Mediwatch are manufacturers and suppliers of high-technology urology products. Mediwatch market a range of urodynamics, ultrasound and biochemistry systems, together with a comprehensive range of urodynamic consumable products.
UroMed Technology - Pelvic Muscle Rehabilitation Business
Acquisition in 2013
UroMed Technology - Pelvic Muscle Rehabilitation Business is a provider of pelvic muscle rehabilitation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.